Home Cart Sign in  
Chemical Structure| 99-24-1 Chemical Structure| 99-24-1

Structure of Methyl gallate
CAS No.: 99-24-1

Chemical Structure| 99-24-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Methyl gallate is a reverse transcriptase inhibitor isolated and purified from sapium sebiferum.

Synonyms: Gallincin; NSC 363001; Gallicin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Methyl gallate

CAS No. :99-24-1
Formula : C8H8O5
M.W : 184.15
SMILES Code : O=C(OC)C1=CC(O)=C(O)C(O)=C1
Synonyms :
Gallincin; NSC 363001; Gallicin
MDL No. :MFCD00002194
InChI Key :FBSFWRHWHYMIOG-UHFFFAOYSA-N
Pubchem ID :7428

Safety of Methyl gallate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H317-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 5, 10, 20 µg/mL 24 hours MG inhibited LPS-induced NO production, regulated macrophage polarization, and suppressed pro-inflammatory cytokine expression. Int J Mol Sci. 2022 Nov 14;23(22):14024.
Methicillin-susceptible Staphylococcus aureus (MSSA) 64 mg/mL 24 hours Evaluated antibacterial activity, forming inhibition zones of approximately 19 mm Polymers (Basel). 2024 Dec 24;17(1):7.
Methicillin-resistant Staphylococcus aureus (MRSA) 64 mg/mL 24 hours Evaluated antibacterial activity, forming inhibition zones of approximately 19 mm Polymers (Basel). 2024 Dec 24;17(1):7.
Differentiated Caco-2 cells 30 µg/mL and 90 µg/mL 48 hours MG showed no cytotoxic effects on differentiated Caco-2 cells. Antioxidants (Basel). 2023 Jun 16;12(6):1292.
LO2 cells 20, 40, 80, 160, 320, 640 µM 48 hours MG showed minimal toxicity in human normal hepatocyte LO2 cells. Front Pharmacol. 2022 Jun 13;13:894285.
Plasmodium falciparum W2 0.61 µg/mL 72 hours Antimalarial activity with IC50 value of 0.61 µg/mL Molecules. 2022 Dec 1;27(23):8382.
Plasmodium falciparum D6 1.57 µg/mL 72 hours Antimalarial activity with IC50 value of 1.57 µg/mL Molecules. 2022 Dec 1;27(23):8382.
Human peripheral blood mononuclear cells (PBMCs) 10 and 50 µM Inhibited IL-1β release in ATP-treated PBMCs Front Pharmacol. 2021 Dec 20;12:759040.
Ralstonia solanacearum 25 mg/ml Evaluate the antibacterial activity of methyl gallate against Ralstonia solanacearum Front Microbiol. 2021 Feb 4;11:598692.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice High-fat diet-induced obesity model Oral 0.1% For 14 weeks Evaluate the effects of VFP or VFPE on weight gain, fat accumulation, glucose and insulin tolerance, energy expenditure, mitochondrial function, hepatic and renal protection, found that VFP and VFPE prevented obesity, improved metabolic flexibility, increased energy expenditure, and protected liver and kidney Int J Mol Sci. 2023 Apr 28;24(9):7984
ICR mice LPS-induced osteoporosis model Oral 10 mg/kg Every 8 days for 8 days Methyl gallate restored LPS-induced osteoporotic phenotype by inhibiting osteoclast formation and bone-resorbing activity. Int J Mol Sci. 2017 Mar 7;18(3):581
C57BL/6 mice Hyperuricemia nephropathy (HN) model Oral 20 and 40 mg/kg Once daily for 28 days Significantly ameliorated HN by inhibiting uric acid production and promoting uric acid excretion as well as ameliorating renal injury induced by NLRP3 activation Front Pharmacol. 2021 Dec 20;12:759040.
BALB/C nude mice Xenograft tumor model Intragastric 40, 80, 160 mg/kg Once daily for 21 days MG significantly inhibited the growth of HCC xenografts, with tumor inhibition rates of 49.94%, 52.66%, and 55.92% respectively. Front Pharmacol. 2022 Jun 13;13:894285.
C57BL/6J mice DSS-induced ulcerative colitis model Oral 50, 100, 200 mg/kg Once daily for 6 days MG alleviated body weight loss, improved colon length and histological damage, modulated gut microbiota, and inhibited TLR4/NF-κB pathway. Int J Mol Sci. 2022 Nov 14;23(22):14024.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00917735 Breast Cancer Phase 2 Completed - United States, Minnesota ... More >> Fairview Southdale Breast Center Edina, Minnesota, United States, 55435 Fairview Maple Grove Breast Center Maple Grove, Minnesota, United States, 55369 University of Minnesota Medical Center (UMMC) Breast Clinic Minneapolis, Minnesota, United States, 55455 Park Nicollet Institute St. Louis Park, Minnesota, United States, 55426 Food Science and Nutrition, University of Minnesota St. Paul, Minnesota, United States, 55108 Less <<
NCT01699711 Down Syndrome (DS) Phase 2 Completed - Spain ... More >> IMIM (Institut Hospital del Mar d'Investigacions Mèdiques) Barcelona, Spain, 08003 Less <<
NCT00917735 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.43mL

1.09mL

0.54mL

27.15mL

5.43mL

2.72mL

54.30mL

10.86mL

5.43mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories